Beximco Pharma reports Tk900cr profit for FY26

Beximco Pharma has posted a profit of Tk900 crore for the 2026 fiscal year. Meanwhile, an application regarding the condonation of delay for the company's 49th Annual General Meeting (AGM) is currently awaiting a High Court verdict. The hearing for this matter has concluded, with the court set to deliver its judgment on 1 November 2026.